← All trials
NCT05384626
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 9, 2022
- Primary completion
- Feb 28, 2026
- Completion date
- Mar 31, 2026
- First posted
- May 20, 2022
- Last posted
- Dec 8, 2022
- Enrollment
- 214
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Nuvalent Inc.Lead sponsor
- Nuvalent Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.